156 related articles for article (PubMed ID: 34979273)
1. Advances in the DNA Nanotechnology for the Cancer Biomarkers Analysis: Attributes and Applications.
Xia LY; Tang YN; Zhang J; Dong TY; Zhou RX
Semin Cancer Biol; 2022 Nov; 86(Pt 2):1105-1119. PubMed ID: 34979273
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Enhancement Strategies for Electrochemical ELISA-Based Immunoassays for Cancer Biomarker Detection.
Arya SK; Estrela P
Sensors (Basel); 2018 Jun; 18(7):. PubMed ID: 29932161
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology in cancer diagnosis: progress, challenges and opportunities.
Zhang Y; Li M; Gao X; Chen Y; Liu T
J Hematol Oncol; 2019 Dec; 12(1):137. PubMed ID: 31847897
[TBL] [Abstract][Full Text] [Related]
4. Nanoswitch-linked immunosorbent assay (NLISA) for fast, sensitive, and specific protein detection.
Hansen CH; Yang D; Koussa MA; Wong WP
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10367-10372. PubMed ID: 28893984
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
Chen X; Wang L; Lou J
Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
[TBL] [Abstract][Full Text] [Related]
6. Emerging nanoproteomics approaches for disease biomarker detection: a current perspective.
Ray S; Reddy PJ; Choudhary S; Raghu D; Srivastava S
J Proteomics; 2011 Nov; 74(12):2660-81. PubMed ID: 21596164
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Devices for Circulating Biomarkers Detection and Quantification.
Bedin C; Crotti S; Tasciotti E; Agostini M
Curr Med Chem; 2018; 25(34):4304-4327. PubMed ID: 29149830
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract][Full Text] [Related]
9. Single Molecule Protein Detection with Attomolar Sensitivity Using Droplet Digital Enzyme-Linked Immunosorbent Assay.
Cohen L; Cui N; Cai Y; Garden PM; Li X; Weitz DA; Walt DR
ACS Nano; 2020 Aug; 14(8):9491-9501. PubMed ID: 32589401
[TBL] [Abstract][Full Text] [Related]
10. One-step detection of pathogens and cancer biomarkers by the naked eye based on aggregation of immunomagnetic beads.
Chen Y; Xianyu Y; Sun J; Niu Y; Wang Y; Jiang X
Nanoscale; 2016 Jan; 8(2):1100-7. PubMed ID: 26666198
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Biosensors for Detecting Cancer-Derived Exosomes.
Cheng N; Du D; Wang X; Liu D; Xu W; Luo Y; Lin Y
Trends Biotechnol; 2019 Nov; 37(11):1236-1254. PubMed ID: 31104858
[TBL] [Abstract][Full Text] [Related]
12. Can nanotechnology improve cancer diagnosis through miRNA detection?
Fiammengo R
Biomark Med; 2017 Jan; 11(1):69-86. PubMed ID: 27917642
[TBL] [Abstract][Full Text] [Related]
13. A copper based enzyme-free fluorescence ELISA for HER2 detection.
Tian S; Zeng K; Yang A; Wang Q; Yang M
J Immunol Methods; 2017 Dec; 451():78-82. PubMed ID: 28919468
[TBL] [Abstract][Full Text] [Related]
14. Rapid and sensitive detection of rare cancer cells by the coupling of immunomagnetic nanoparticle separation with ELISA analysis.
Cheng HY; Lai LJ; Ko FH
Int J Nanomedicine; 2012; 7():2967-73. PubMed ID: 22787392
[TBL] [Abstract][Full Text] [Related]
15. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
[TBL] [Abstract][Full Text] [Related]
16. Advancing the speed, sensitivity and accuracy of biomolecular detection using multi-length-scale engineering.
Kelley SO; Mirkin CA; Walt DR; Ismagilov RF; Toner M; Sargent EH
Nat Nanotechnol; 2014 Dec; 9(12):969-80. PubMed ID: 25466541
[TBL] [Abstract][Full Text] [Related]
17. Selecting clinically-driven biomarkers for cancer nanotechnology.
Phan JH; Young AN; Wang MD
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():3317-20. PubMed ID: 17947020
[TBL] [Abstract][Full Text] [Related]
18. Aggregation-Induced Emission Luminogen-Based Dual-Mode Enzyme-Linked Immunosorbent Assay for Ultrasensitive Detection of Cancer Biomarkers in a Broad Concentration Range.
Shen J; Situ B; Du X; Wang Z; Hu R; Li B; Qin A; Tang BZ
ACS Sens; 2022 Mar; 7(3):766-774. PubMed ID: 35179886
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers.
Hong S; Wang AZ
Adv Drug Deliv Rev; 2018 Feb; 125():1-2. PubMed ID: 29880212
[No Abstract] [Full Text] [Related]
20. DNA Nanomachines for Identifying Cancer Biomarkers in Body Fluids and Cells.
Dong Z; Xue X; Liang H; Guan J; Chang L
Anal Chem; 2021 Feb; 93(4):1855-1865. PubMed ID: 33325676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
